Evercore ISI lowered the firm’s price target on Exact Sciences to $72 from $80 and keeps an Outperform rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls
- Scotiabank starts Exact Sciences with Outperform, sees ‘plenty of runway’
- Exact Sciences initiated with an Outperform at Scotiabank
- Exact Sciences price target lowered to $70 from $80 at BTIG
- Exact Sciences price target lowered to $73 from $90 at Guggenheim